Webinar: CHMP OEs and FDA ADCOMs – Navigating the Differences to Prepare for Success

by Kell Cannon & Michelle Zucatti

To request access to this content please complete the form below.

In this webinar, 3D Communications' Kell Cannon and Michelle Zucatti share similarities and differences in regulatory pathways between the FDA and EMA and strategies to overcome communications challenges – and ultimately win a majority vote.

Whether you are responsible for a single regulatory application, leading a team, or managing a broader regulatory portfolio, this webinar will enable you to navigate the opportunities and challenges with communicating to US and EU regulatory bodies with confidence.

Register above to receive a recording of the session and a copy of the presentation slides.

  • Share On

Recommended Posts

Want to Succeed at Your FDA Advisory Committee Meeting? Don’t Ignore the Power of a First Impression

Going Back to the Basics of Effective Communications – How Manufacturers Should Approach Medicare’s Drug Price Negotiation Program

Leveraging an Investigative Reporting Toolbox – An Untraditional Approach to Media Training

Aligning a Corporate Narrative—and Leaders—for Effective Communications

How Can We Help You?

Get Started